These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7511819)

  • 1. Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2.
    Gomi H; Tagaya Y; Nakano T; Mikayama T; Ishizaka K
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2824-8. PubMed ID: 7511819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope specificity of bee venom phospholipase A2-specific suppressor T cells which produce antigen-binding glycosylation inhibiting factor.
    Mori A; Thomas P; Tagaya Y; Iijima H; Grey H; Ishizaka K
    Int Immunol; 1993 Aug; 5(8):833-42. PubMed ID: 7691164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation-inhibiting factor from human T cell hybridomas constructed from peripheral blood lymphocytes of a bee venom-sensitive allergic patient.
    Thomas P; Gomi H; Takeuchi T; Carini C; Tagaya Y; Ishizaka K
    J Immunol; 1992 Feb; 148(3):729-37. PubMed ID: 1730869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. I. Identification of a 55-kilodalton glycosylation-inhibiting factor peptide with TCR alpha-chain determinant.
    Nakano T; Ishii Y; Ishizaka K
    J Immunol; 1996 Mar; 156(5):1728-34. PubMed ID: 8596020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the "major histocompatibility complex subregion" I-J determinant with bioactive glycosylation-inhibiting factor.
    Nakano T; Liu YC; Mikayama T; Watarai H; Taniguchi M; Ishizaka K
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9196-200. PubMed ID: 7568100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of certain epitope specificities of glycosylation inhibiting factor for the suppression of in vivo IgE and IgG antibody responses.
    Yamaguchi K; Mori A; Ohno H; Tagaya Y; Ishizaka K
    Int Immunol; 1992 Mar; 4(3):337-46. PubMed ID: 1373642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phospholipase A2 inhibitors on mouse T lymphocytes. II. Phospholipase A2 inhibitors induce T cell hybridomas and a T cell clone for the formation of glycosylation-inhibiting factor.
    Ohno H; Iwata M; Katamura K; Ishizaka K
    Int Immunol; 1990; 2(3):257-66. PubMed ID: 2128469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of glycosylation-inhibiting factor with plasma membranes of T suppressor cell hybridomas.
    Iwata M; Katamura K; Mori A; Yamagushi K; Grey H; Ishizaka K
    J Immunol; 1990 Dec; 145(11):3578-88. PubMed ID: 2147196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method to generate antigen-specific suppressor T cells in vitro from peripheral blood T cells of honey bee venom-sensitive, allergic patients.
    Carini C; Iwata M; Warner J; Ishizaka K
    J Immunol Methods; 1990 Mar; 127(2):221-33. PubMed ID: 2138201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor.
    Mikayama T; Nakano T; Gomi H; Nakagawa Y; Liu YC; Sato M; Iwamatsu A; Ishii Y; Weiser WY; Ishizaka K
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10056-60. PubMed ID: 8234256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phospholipase A2 inhibitors on mouse T lymphocytes. I. Phospholipase A2 inhibitors exert similar immunological activities as glycosylation inhibiting factor.
    Ohno H; Iwata M; Nakamura T; Ishizaka K
    Int Immunol; 1989; 1(4):425-33. PubMed ID: 2535136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between T cell receptors and antigen-binding factors. I. Specificity of functional T cell receptors on mouse T cell hybridomas that produce antigen-binding T cell factors.
    Iwata M; Katamura K; Kubo RT; Ishizaka K
    J Immunol; 1989 Dec; 143(12):3909-16. PubMed ID: 2480378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. II. The 55-kDa glycosylation-inhibiting factor peptide is a derivative of TCR alpha-chain and a subunit of antigen-specific glycosylation-inhibiting factor.
    Ishii Y; Nakano T; Ishizaka K
    J Immunol; 1996 Mar; 156(5):1735-42. PubMed ID: 8596021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization of murine glycosylation-inhibiting factor.
    Tagaya Y; Mori A; Ishizaka K
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9117-21. PubMed ID: 1924374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF.
    Watarai H; Nozawa R; Tokunaga A; Yuyama N; Tomas M; Hinohara A; Ishizaka K; Ishii Y
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13251-6. PubMed ID: 11069294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgE-binding factors and regulation of the IgE antibody response.
    Ishizaka K
    Annu Rev Immunol; 1988; 6():513-34. PubMed ID: 3289576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro modulation of antigen-primed T cells by a glycosylation-inhibiting factor that regulates the formation of antigen-specific suppressive factors.
    Iwata M; Ishizaka K
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2444-8. PubMed ID: 2951740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human monoclonal or polyclonal antibodies recognize predominantly discontinuous epitopes on bee venom phospholipase A2.
    Schneider T; Lang AB; Carballido JM; Santamaria Babi LF; Dudler T; Kägi MK; Blaser K; Suter M
    J Allergy Clin Immunol; 1994 Jul; 94(1):61-70. PubMed ID: 7517969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the antibody response to bee venom phospholipase A2 induced by natural exposure in humans or by immunization in mice.
    Schneider T; Dudler T; Annand RR; Gelb MH; King TP; Suter M
    J Mol Recognit; 1997; 10(2):93-100. PubMed ID: 9376132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier-specific suppression of antibody responses by antigen-specific glycosylation-inhibiting factors.
    Jardieu P; Akasaki M; Ishizaka K
    J Immunol; 1987 Mar; 138(5):1494-501. PubMed ID: 3492554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.